Table 1 The baseline characteristics of patients in training and validation cohort

General

170^a

63^a

 Gender

135:35^a

47:16^a

0.04*

 Age(years)

56 (54–58)

57 (54–60)

0.69

Biochemical data

 BMI(kg/m²)

23.92 (23.56–24.47)

23.64 (22.95–24.34)

0.75

 PLT(×10⁹/L)

149.54 (137.64–161.40)

142.49 (127.82–157.35)

0.19

 ALT(IU/L)

51.29 (38.58–63.95)

72.01 (54.75–89.29)

0.005*

 AST(IU/L)

48.82 (36.92–60.72)

59.19 (26.89–91.49)

0.27

 TB(µmol/L)

20.33 (17.61–23.01)

28.53 (21.88–35.19)

0.009*

 DB(µmol/L)

5.66 (3.65–7.67)

8.26 (4.41–12.09)

0.09

 APRI

1.36 (0.88–1.83)

1.03 (0.86–1.20)

0.68

 FIB-4

3.65 (2.91–4.39)

3.94 (1.48–6.40)

0.59

Histopathology

 Fibrosis stage

  S0

10^a

1^a

  S1

23^a

11^a

  S2

37^a

12^a

  S3

18^a

11^a

  S4

82^a

28^a

 Inflammatory activity

  G0

7^a

1^a

  G1

45^a

9^a

  G2

82^a

28^a

  G3

23^a

19^a

  G4

13^a

6^a